Capital Fund Management (CFM)
UTHR icon

Capital Fund Management (CFM)’s United Therapeutics UTHR Stock Holding History

Capital Fund Management (CFM)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,100
Closed -$798K – 2291
2018
Q1 		$798K Buy
+7,100
New +$902K ﹤0.01% 1307

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital Fund Management (CFM)'s UTHR Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its United Therapeutics (UTHR) stake by 47% in Q1 2026, buying an estimated $7.77M and bringing the position to 48,964 shares worth $29M. The position accounts for 0.13% of the portfolio, ranked #194.

Capital Fund Management (CFM) first reported a position in UTHR in Q2 2013 and has held it in 31 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Capital Fund Management (CFM) held 48,964 shares of United Therapeutics worth $29M as of Q1 2026.
  • Capital Fund Management (CFM) bought 15,605 United Therapeutics shares in Q1 2026, an estimated $7.77M.
  • United Therapeutics made up 0.13% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #194 holding.
  • Capital Fund Management (CFM) first reported a position in United Therapeutics in Q2 2013 and has held it in 31 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.